Back

Prognostic impact of sarcopenia on major adverse cardiovascular outcomes in coronary artery disease patients undergoing successful percutaneous coronary intervention

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Assessment of residual risk after percutaneous coronary intervention Comorbidities ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Dong Oh Kang

Korea University Guro Hospital, Seoul (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
Validation of quantitative flow reserve and residual quantitative flow reserve to predict fractional flow reserve post stenting from the DOCTORS study population
Doctor J. Adjedj (Saint Laurent du Var, FR)
Abstract Slides
Presentation thumbnail
Percutaneous coronary intervention versus medical therapy for coronary lesions with positive fractional flow reserve (FFR) but preserved coronary flow reserve (CFR). A substudy of the COMPARE-ACUTE
Doctor J. Haeck (Leeuwarden, NL)
Abstract Slides
Presentation thumbnail
Diagnostic performance of quantitative flow ratio from coronary angiography versus fractional flow reserve from computed tomography
Doctor H. Emori (Wakayama, JP)
Abstract Slides
Presentation thumbnail
Long-term risk stratification of patients undergoing coronary angiography according to the TIMI risk score for secondary prevention
Doctor B. Zafrir (Haifa, IL)
Abstract Slides

Access the full session

Session thumbnail
Assessment of residual risk after percutaneous coronary intervention

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources